Founders - StrideBio
Our mission is to develop best-in-class gene therapies for people with life-threatening diseases. Our vision is to be the leader in the evolution of gene therapy and be known for superior drug development, high industry standards, extraordinary integrity and an innovative team that translates science into treatments that prolong and improve lives.
This company is:
Verified
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform - StrideBio
StrideBio, Inc, a US-based company developing novel AAV vectors for in vivo gene therapies announced today that it had closed an oversubscribed Series A Financing Round of $15.7 million.
Verified
Our Approach - StrideBio
Gene therapy promises single-dose therapy with sustained benefit, reducing or potentially eliminating the need for chronic or long-term treatment. In gene therapy, genetic material is ...
Verified
StrideBio Appoints Maritza McIntyre, Ph.D., as Chief Development Officer - StrideBio
StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene therapies, today announced the appointment of Maritza McIntyre, Ph.D., as Chief Development Officer.
View all products
Keywords
Industries
CRISPR Therapeutics and Casebia Therapeutics Announce Exclusive Development and Option Agreement with StrideBio - StrideBio
CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Casebia Therapeutics, a joint-venture established by CRISPR Therapeutics and Bayer AG for developing CRISPR-based therapeutics in select disease areas, today announced they have signed a collaboration agreement with StrideBio, LLC, a US-based company developing novel AAV vectors for in vivo gene delivery applications.
Where is StrideBio located?
The company StrideBio is located in Durham, North Carolina, United States. It's worth noting that the company may has more corporate locations
How many employees does StrideBio approximately have?
As of the latest available information StrideBio has around 51-100 employees worldwide.
When was StrideBio founded?
StrideBio was founded in 2015
In which industries does StrideBio mainly work?
The company StrideBio has it's main focus in the industries of Biotechnology
What is the current company status of StrideBio?
Based on the founding year and the amount of employees the company StrideBio seems to be a Medium-Sized Company at the current state. Note that over time that status can change
Kriya Therapeutics
United States
51-100 Employees
2019
View
GenSight Biologics
France
11-50 Employees
2012
View
Jaguar Gene Therapy
United States
11-50 Employees
2019
View
Scopus BioPharma
United States
1-10 Employees
2018
View
Life Edit
United States
11-50 Employees
2017
View
Spark Therapeutics
United States
51-100 Employees
2013
View
Legend Biotech
United States
101-250 Employees
2014
View
BridgeBio Pharma
United States
251-500 Employees
2014
View
Topics which have been searched by others and may be interesting for you:
